Project: Sensitive diagnosis, prognosis and treatment planning on open platform of glioma brain tumours
| Acronym | SensiScreen Glioma (Reference Number: 12513) |
| Duration | 01/10/2018 |
| Project Topic | Be first on market with single-platform assays covering all biomarkers recommended by EANO guidelines for glioma patients. The key breakthrough technical developments of our proprietary assays being the ability to monitor disease progression using liquid biopsies and the non-trivial multiplexing of assays, which target very different genetic biomarkers in one combined solution, while we achieve and retain an unprecedented sensitivity and selectivity with respect to the individual biomarkers. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 9 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | PentaBase ApS | Coordinator | Denmark |
| 2 | Istituto Cantonale di Patologia | Partner | Switzerland |
| 3 | Danish Technological Institute | Partner | Denmark |